Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Elizabeth Arden, Inc. (RDEN)

Page 1 of 2

Is Elizabeth Arden, Inc. (NASDAQ:RDEN) a good investment?

In the financial world, there are tons of indicators investors can use to watch the equity markets. A couple of the most useful are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best money managers can outclass the broader indices by a very impressive amount (see just how much).

Equally as useful, positive insider trading activity is another way to look at the world of equities. There are a number of stimuli for a bullish insider to downsize shares of his or her company, but just one, very clear reason why they would initiate a purchase. Various empirical studies have demonstrated the valuable potential of this method if shareholders understand where to look (learn more here).

What’s more, we’re going to study the recent info about Elizabeth Arden, Inc. (NASDAQ:RDEN).

Hedge fund activity in Elizabeth Arden, Inc. (NASDAQ:RDEN)

At Q2’s end, a total of 7 of the hedge funds we track held long positions in this stock, a change of -22% from the previous quarter. With the smart money’s capital changing hands, there exists a few noteworthy hedge fund managers who were increasing their holdings significantly.

Elizabeth Arden, Inc. (NASDAQ:RDEN)When using filings from the hedgies we track, Fisher Asset Management, managed by Ken Fisher, holds the biggest position in Elizabeth Arden, Inc. (NASDAQ:RDEN). Fisher Asset Management has a $49.9 million position in the stock, comprising 0.1% of its 13F portfolio. Coming in second is Phill Gross and Robert Atchinson of Adage Capital Management, with a $4.1 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. Remaining peers with similar optimism include Richard Driehaus’s Driehaus Capital, Mario Gabelli’s GAMCO Investors and Cliff Asness’s AQR Capital Management.

Due to the fact Elizabeth Arden, Inc. (NASDAQ:RDEN) has witnessed a fall in interest from the smart money’s best and brightest, it’s easy to see that there was a specific group of funds who were dropping their entire stakes in Q1. It’s worth mentioning that Ken Griffin’s Citadel Investment Group dumped the largest position of the 450+ funds we key on, valued at close to $0.8 million in stock. Paul Tudor Jones’s fund, Tudor Investment Corp, also sold off its stock, about $0.3 million worth. These bearish behaviors are interesting, as aggregate hedge fund interest fell by 2 funds in Q1.

How are insiders trading Elizabeth Arden, Inc. (NASDAQ:RDEN)?

Bullish insider trading is most useful when the company in focus has experienced transactions within the past 180 days. Over the latest 180-day time period, Elizabeth Arden, Inc. (NASDAQ:RDEN) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to Elizabeth Arden, Inc. (NASDAQ:RDEN). These stocks are Energizer Holdings, Inc. (NYSE:ENR), Blyth, Inc. (NYSE:BTH), Nu Skin Enterprises, Inc. (NYSE:NUS), Inter Parfums, Inc. (NASDAQ:IPAR), and Revlon Inc (NYSE:REV). This group of stocks are in the personal products industry and their market caps are similar to RDEN’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!